The identification of senolytics, compounds that eliminate senescent cells, is presently a key priority given their therapeutic promise in cancer and aging-associated diseases. Two recent papers by Triana-Martínez et al. and Guerrero et al. report the senolytic activity of cardiac glycosides (CGs) and their efficacy in these pathophysiological contexts.

中文翻译：

---

心脏糖苷作为缓溶化合物。

考虑到它们在癌症和与衰老相关的疾病中的治疗前景，鉴定senolytics（消除衰老细胞的化合物）目前是关键的优先事项。Triana-Martínez等人最近发表了两篇论文。和Guerrero等。报告了强心苷（CGs）的衰老活性及其在这些病理生理学背景下的功效。